Advancements in Small Cell Lung Cancer Treatment

This chapter examines the latest treatment options for small cell lung cancer, including the impact of the Adriatic trial showcasing immunotherapy with dervalumab for limited-stage cases. It contrasts these advancements with current chemotherapy protocols for extensive-stage patients, highlighting improved survival rates and changing standards of care.